iiinova — where your digital self keeps evolving

Lewis C. E. Mason @lewiscemason.bsky.social · 03/09/2026

Many thanks for inviting me to help write this article!

Lewis C. E. Mason @lewiscemason.bsky.social · 02/09/2026

Given the data report by the UK Health Security Agency (UKHSA) regarding the increase in giardiasis cases, it has been a pleasure to write this article discussing potential reasons for this rise in cases. doi.org/10.64628/AB....

doi.org

Giardiasis cases are rising in England: should we be worried?

Giardia causes hundreds of millions of infections globally each year.

000

Lewis C. E. Mason @lewiscemason.bsky.social · 28/08/2026

I really enjoyed helping to write this article, thanks @uk.theconversation.com !

000

Lewis C. E. Mason @lewiscemason.bsky.social · 12/07/2026

Also please view Professor Kate Baker’s post about this new article: bsky.app/profile/ksba...

000

Reposted by Lewis C. E. Mason

Kate Baker @ksbakes.bsky.social · 09/07/2026

👀👇 New work on sexually transmitting Shigella (press-friendly: bit.ly/4bBarEL) From continued collaboration with @clairejenkins2.bsky.social @ukhsa.bsky.social, @pducambridge.bsky.social co-lead @hsalje.bsky.social, a talented student Julia Marshall www.linkedin.com/in/julia--ma..., and others! 🧫🧬💊

11311

Lewis C. E. Mason @lewiscemason.bsky.social · 13/04/2026

My favourite is: Abstract, Introduction, Results & Discussion (combined), Methods.

000

Lewis C. E. Mason @lewiscemason.bsky.social · 26/03/2026

The syphilis article is super interesting - thanks for sharing!

010

Lewis C. E. Mason @lewiscemason.bsky.social · 26/03/2026

I am so sorry to hear this @metrocharity.bsky.social , thank you for all the incredibly useful input you have had into guiding the direction of my sexually transmissible infection research

010

Lewis C. E. Mason @lewiscemason.bsky.social · 04/03/2026

Hi Erik, please could you add me to this feed? scholar.google.com/citations?us...

scholar.google.com

000

Reposted by Lewis C. E. Mason

The Lancet Microbe @lancetmicrobe.bsky.social · 04/03/2026

New personal view article The role of microbial genomics in delivering the UK’s national action plan for confronting antimicrobial resistance 2024–29 www.thelancet.com/journals/lan... #IDSky #ClinMicro #AMR #OpenAccess #OA

22018

Lewis C. E. Mason @lewiscemason.bsky.social · 04/03/2026

Many thanks for involving me with the TARGetAMR group work, it really is wonderful to see this piece in press!

030

Reposted by Lewis C. E. Mason

Kate Baker @ksbakes.bsky.social · 04/03/2026

Many thanks to lead authors @drtessjohnson.bsky.social and @lewiscemason.bsky.social team @target-amr.bsky.social and our wonderful stakeholders who joined in and shared their invaluable views and experiences! 7/n

143

Lewis C. E. Mason @lewiscemason.bsky.social · 03/03/2026

Absolutely - can never overstate the importance of hygiene in helping to prevent the spread of enteric infections!

011

Reposted by Lewis C. E. Mason

The Shigella Meeting @shigellameeting.bsky.social · 22/01/2026

Did you know shigellosis also transmits as a sexually transmissible illness? This has increased since the early 2000s with marked AMR. Read the back story on ST shigellosis emergence here, and come to Paris for #Shigella2026 to find out more! doi.org/10.1099/mgen...

doi.org

The natural history of the emergence of sexually transmissible shigellosis

Shigellosis is a gastrointestinal illness caused by bacteria belonging to one of four species of Shigella. Sexually transmissible (ST) shigellosis was first reported in 1974, but recently there has be...

043

Lewis C. E. Mason @lewiscemason.bsky.social · 23/01/2026

Why did sexually transmissible #shigellosis outbreak reporting increase in the early 2000s? Our new article explores the genomic epidemiology of two #Shigella sonnei outbreaks in London and Berlin, alongside a temporal/spatial literature review. 🛟🧪🧬🖥️🦠💉🧫😷 www.microbiologyresearch.org/content/jour...

microbiologyresearch.org

The natural history of the emergence of sexually transmissible shigellosis

185

Lewis C. E. Mason @lewiscemason.bsky.social · 07/10/2025

I am very pleased to announce that I have started a new role as a Lecturer in Biological Sciences (Microbiology) at Kingston University ( @kingstonuniversity.bsky.social ). I am really looking forward to sharing my expertise and knowledge in infection, immunity, bioinformatics, and microbiology!

060

Lewis C. E. Mason @lewiscemason.bsky.social · 16/08/2025

My current Postdoctoral Research position is due to end on 30th September 2025. I am keen to continue working in infectious disease research, data-driven epidemiology, and teaching in academia, public health, and/or industry. If you know of any opportunities, please do let me know - thank you!

077

Reposted by Lewis C. E. Mason

Kate Baker @ksbakes.bsky.social · 07/08/2025

I hope all my fellow #shigellaphiles have 20 - 24 April 2026 blocked out in their diaries for @shigellameeting.bsky.social next year in Paris! In the meantime, check out (and join) our starter pack to start community building now 🧫

046

Reposted by Lewis C. E. Mason

The Shigella Meeting @shigellameeting.bsky.social · 07/08/2025

Why not follow our @shigellameeting.bsky.social starterpack of people who are speaking at and attending the conference - please message to be added to the starter pack if you're planning on coming or we haven't found you yet! go.bsky.app/6Vbwhjc

064

Reposted by Lewis C. E. Mason

Kate Baker @ksbakes.bsky.social · 27/07/2025

There are half a million cases of invasive non-Typhoidal Salmonella (iNTS) every year and while you might know S. Typhimurim and Enteritidis, you may not have heard of S. Panama 💩 🩸 🧫 💊 Check out our latest in @lancetmicrobe.bsky.social doi.org/10.1016/j.la... and the 🧵 below to find out more 1/n

25827

Reposted by Lewis C. E. Mason

Willem van Schaik @wvschaik.bsky.social · 20/07/2025

'The University of Birmingham is one of the UK research institutions to each receive £4.35 million of funding from the Global Talent Fund – a Department for Science, Innovation and Technology (DSIT) resource supporting the movement of global academic talent' www.birmingham.ac.uk/news/2025/un...

birmingham.ac.uk

University of Birmingham chosen among elite UK research funding recipients - University of Birmingham

Birmingham is one of 12 UK research institutions to share £54 million of funding from the Global Talent Fund.

1175

Reposted by Lewis C. E. Mason

UK Health Security Agency @ukhsa.bsky.social · 09/06/2025

🆕 The UK becomes one of the first countries in the world to issue national evidence-based doxyPEP guidelines. This is a step forward in targeted STI prevention and addressing the continuing rise in syphilis cases in the UK. 🔗 www.bashh.org/news/1686/ba...

DoxyPEP is now available for gay and bisexual men and transgender women at risk of getting syphilis.

165

Lewis C. E. Mason @lewiscemason.bsky.social · 04/07/2025

Hi Ferric, many thanks for your reply to this post alongside the publication. I was just wondering, which antibiotic treatment was used to target the outbreak strain? In UK GBMSM-associated isolates we have seen >30% triple-resistance to CIP, AZM, and Ceftriaxone. www.thelancet.com/journals/lan...

thelancet.com

Using demographics of patients to inform treatment of shigellosis in England

Shigellosis, caused by bacteria of the genus Shigella, is a diarrhoeal disease transmitted by the faecal–oral route.1 Rapid increases in the prevalence of extensively drug-resistant (XDR) Shigella iso...

100

Lewis C. E. Mason @lewiscemason.bsky.social · 04/07/2025

Hi Marco, very interesting work regarding Shigella flexneri survival of environmental stresses within/outside of host cells. Will definitely be awaiting any further publications from yourself / your group regarding this, I always have an appetite to learn more about Shigella species biology!

110

Reposted by Lewis C. E. Mason

Marco Coluccia @marco-coluccia.bsky.social · 26/06/2025

First post on Bluesky and first time at #EMBL in #Heidelberg. I am happy to present my poster on #Shigella at #EESMicrobiology!

291

Reposted by Lewis C. E. Mason

Charlotte Houldcroft @virologyhouldcroft.bsky.social · 04/07/2025

Ipswich looking glorious in the sun. Brilliant 48h with the @pducambridge.bsky.social solving the pressing questions in infectious diseases, competing in penalty shoot outs and cooking up a storm #PDURetreat

065

Reposted by Lewis C. E. Mason

Pathogen Dynamics Unit @pducambridge.bsky.social · 23/05/2025

Check out the latest from the lab on Sexually Transmissible shigellosis where @lewiscemason.bsky.social and co unpick why this relatively obscure disease re-emerged endemically in the 21st Century 🔬 🧫 🕵️ 🧬

074

Reposted by Lewis C. E. Mason

Kate Baker @ksbakes.bsky.social · 23/05/2025

Sexually transmissible shigellosis has gone from an obscure cause of sporadic outbreaks to a sustained endemic AMR priority in only two decades! 🧫💊 Check out our latest preprint to understand how this happened 1/11 www.medrxiv.org/content/10.1...

medrxiv.org

The natural history of the emergence of sexually transmissible shigellosis

Shigellosis is a gastrointestinal illness caused by bacteria belonging to one of four species of Shigella . Sexually transmissible shigellosis was first reported in 1974, but recently there has been a...

14734

Lewis C. E. Mason @lewiscemason.bsky.social · 06/05/2025

Why did sexually transmissible shigellosis outbreak reporting re-emerge in the early 2000s? Below, our preprint explores the genomic epidemiology and temporal dating of Shigella sonnei from two early outbreaks in London & Berlin. 🛟🧪🧬🖥️🦠💉🧫😷https://www.medrxiv.org/content/10.1101/2025.05.02.25326874v1

medrxiv.org

The natural history of the emergence of sexually transmissible shigellosis

020

Lewis C. E. Mason @lewiscemason.bsky.social · 21/01/2025

Antimicrobial resistant Shigella spp. continue to transmit internationally. Our commentary in Lancet Microbe explores combining patient demographics and bacterial genomics to inform antimicrobial treatment. 🛟🧪🧬🖥️🦠💉🧫😷https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00294-5/fulltext

thelancet.com

Using demographics of patients to inform treatment of shigellosis in England

0225

Lewis C. E. Mason @lewiscemason.bsky.social · 04/08/2024

We are pleased to announce that our work investigating the genomics and patient demographics of re-emerging MDR Shigella flexneri 3a in England has been accepted in Nature Antimicrobials and Resistance, and is available to view Open-Access. 🛟🧪🧬🖥️🦠💉🧫😷 doi.org/10.1038/s442...

doi.org

The re-emergence of sexually transmissible multidrug resistant Shigella flexneri 3a, England, United Kingdom - npj Antimicrobials and Resistance

npj Antimicrobials and Resistance - The re-emergence of sexually transmissible multidrug resistant Shigella flexneri 3a, England, United Kingdom

1137

Lewis C. E. Mason @lewiscemason.bsky.social · 02/02/2024

Between 2009-2014, an epidemic of sexually transmissible Shigella flexneri 3a occurred in England that subsequently declined. However, from 2018-2021, S. flexneri 3a re-emerged. We explored possible drivers of the re-emergence by comparing host demographic features and pathogen genomics. 🛟🧪🧬🖥️🦠💉🧫😷

researchsquare.com

The re-emergence of sexually transmissible multidrug resistant Shigella flexneri 3a, England, United...

Shigellosis is an enteric infection that transmits through the faecal-oral route, which can occur during sex between men who have sex with men (MSM). Between 2009 and 2014, an epidemic of sexually tra...

0105

Lewis C. E. Mason @lewiscemason.bsky.social · 30/11/2023

Hi Dani, thanks for your reply, and sure thing - here is an article I was recently the first author on: www.nature.com/articles/s41...

110

Lewis C. E. Mason @lewiscemason.bsky.social · 27/11/2023

Hi Sean, yes please that would be great!

010